EVOLVE: Difference between revisions

Jump to navigation Jump to search
63 bytes added ,  21 August 2015
No edit summary
Tag: visualeditor
Line 205: Line 205:
* High drug discontinuation rates (66.7% vs. 70.5%)
* High drug discontinuation rates (66.7% vs. 70.5%)
* High drop-in rates in the placebo group (use of commercial cinacalcet)
* High drop-in rates in the placebo group (use of commercial cinacalcet)
* Under the initial assumption of a 20% treatment effect, the study power dropped to 54%
* Under the initial assumption of a 20% treatment effect, the study power dropped to 54%<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983668/</ref>


==Funding==<!-- remove when cleared by an editor -->
==Funding==<!-- remove when cleared by an editor -->
495

edits

Navigation menu